Wuyao Pharmaceutical

Wuhan Wuyao Pharmaceutical is a China-based pharmaceutical manufacturer focused on active pharmaceutical ingredients (APIs), intermediates, and related raw materials. The company appears to operate primarily as a commercial API and generic pharmaceutical supplier rather than a discovery-stage biotech, with more than 40 marketed API products and international regulatory certifications referenced by industry directories. Publicly described products include metamizole sodium, metronidazole, enoxacin, pirenoxine sodium, tirofiban hydrochloride, norepinephrine bitartrate, epinephrine, hydroxychloroquine sulfate, and glipizide. The company is described as a holding subsidiary of Grand Pharmaceutical (China) and has manufacturing operations in Hubei, China serving both domestic and export markets. Overall, it is best characterized as an established commercial pharmaceutical manufacturing business with GMP-oriented API production capabilities.